Rexahn Initiates Phase IIa Clinical Trial of Archexin® in Patients with Metastatic Renal Cell Carcinoma Jan 14, 2014
Rexahn Receives Method Patent for Treatment of Solid Tumor Cancers for Supinoxin TMÂ (RX-5902) Dec 11, 2013
Rexahn Pharmaceuticals In-Licenses Novel Oligonucleotide Targeted Drug Delivery Platform from Ohio State University Oct 10, 2013
Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117 Sep 30, 2013